Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement

NCT00905437 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class

Stopped The Study was terminated on May 24th 2012 due to a slow recruitment rate. The study was not terminated for reasons of safety or efficacy.

Conditions

Interventions

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.